奥地利科学研究院癌症免疫疗法博士后职位

The research group of Robert Kralovics at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna is looking for highly motivated individuals with experience in the fields of cancer immunotherapy and/or antibody engineering. The group has recently identified novel mutations in the gene CALR in MPN patients. The objective of the project is to develop new therapeutic strategies for CALR-positive MPN (Klampfl et. al., N Engl J Med 369(25):2379-90, 2013).

Requirements and desired qualifications:

• PhD in immunology, molecular biology or biochemistry
• high accuracy and reliability
• excellent interpersonal skills and ability to work in an
• international team
• very good/excellent written and oral communication skills in English
• previous experience with antibody production or engineering, vaccine development, mouse models, cancer immunotherapy are preferred

Deadline for Applications: 15 March 2014

CeMM is the novel, international, independent and interdisciplinary Research Center for Molecular Medicine of the Austrian Academy of Sciences committed to advancing the understanding of human diseases through basic and biomedical research. Located in a tailor-made building in the midst of the campus of the Medical University of Vienna, CeMM is dedicated to its mission statement “from the clinic to the clinic” and fosters a highly collaborative and interactive research mindset. The official language at CeMM is English.